Clinical trials show progress in migraine frequency, skin cancer prevention
-
6:04
Examining Meagan Wolfe’s future
-
1:34
Drivers give mixed reviews of Southeastern Wisconsin’s first...
-
2:39
’I am very thankful’: West Allis grocer reports surge in...
-
1:03
USS Beloit commissioned during ceremony at Milwaukee’s Veterans...
-
0:23
Police investigating shooting near Milwaukee bowling alley; 1...
-
1:55
Schlesinger’s Saturday Showcase (11/23)...Holiday Folk Fair,...
-
3:14
Quiet weekend weather for hunters & then a few precip chances...
-
1:42
CBS 58, Brewers Drive-Thru Food Drive collects 558 turkeys, more...
-
2:05
Slinger claims Division 2 state title on late heroics, Muskego...
-
2:24
Fire destroys historic Meinhardt Mansion in Burlington, property...
-
2:38
Removing I-794 would bring $475 million in property taxes, create...
-
2:41
Cannons roar in preparation for commissioning ceremony of USS...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.